Contact
Home • Our expertise • Value, Pricing & Access • Evidence Synthesis & RWE Generation

Evidence Synthesis & RWE Generation.

Strengthen your evidence base and value proposition.

Get in touch with a Value, Pricing & Access expert

What we do.

Tap the burgeoning wealth of real-world data and literature to strengthen your evidence generation strategy and value proposition.

Our team of evidence synthesis and real-world evidence analytics experts will help you navigate what’s possible, design innovative study approaches, and execute flawlessly.

How we help.

Work with us to define and deliver a credible value story with expert evidence synthesis and pan-global RWE generation, including for HTA submissions.

Learn about our Centers of Excellence

Our highly experienced and dedicated teams conduct:

  • Systematic and pragmatic/targeted literature reviews to support HTA submissions, economic modelling, value
    proposition development, and data analytics and strategic insight generation
  • Quantitative evidence synthesis, including NMAs, MAICs, STCs, trial data, RWE, and economic evaluations
  • Real-world data analytics, including epidemiology, treatment pathways, clinical outcomes, and HCRU

Featured case study

Indirect treatment comparison to generate comparative effectiveness.

The team delivered comparative effectiveness evidence against competitors to support HTA activities for a client approaching a competitive market.
View all case studies
Featured

Indirect treatment comparison (ITC) to generate comparative effectiveness evidence

A company was approaching the European market with evidence from a placebo-controlled RCT, but with several established competitors.

Read more

Get to know some of our experts.

Cormac Sammon

Partner, RWE & Data Analytics

Read bio

Donna Fountain

Partner, Market Access

Read bio

Ravi Potluri

Partner, HEOR & RWE

Read bio

Latest thinking.

Get the latest insights and perspectives from our experts.

View all of our resources

Indirect treatment comparison (ITC) to generate comparative effectiveness evidence

A company was approaching the European market with evidence from a placebo-controlled RCT, but with several established competitors.

Read more

Webinar on the IRA in partnership with BioCentury

Scott Briggs, Principal, joined a live panel of industry experts to discuss the Inflation Reduction Act on March 30th. 

Read more

HTA evidence generation and preparedness for a novel oncology treatment

Our client needed successful HTA evidence packages and submissions to achieve reimbursement across Europe for an innovative oncology treatment.

Read more

Early value insights to drive value definition and evidence need to produce TrPP

The client wanted to understand the key drivers of value for the new treatment for sleep disorders including narcolepsy.

Read more

Get in touch.

Looking to get in touch with an expert or team member?

Tell us how we can help.

Contact us today

Related offerings.

Value, Pricing & Access

Learn more

HEOR Evidence Generation

Learn more

Value, Pricing & Access Strategy

Learn more
View all of our areas of expertise